The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

Article Information

doi

History

¹Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA
²Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
³Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
⁴Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
⁵Department of Surgery, Duke University, Durham, NC 27710, USA
⁶Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
⁷Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA
⁸Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC 27710, USA
⁹Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA
¹⁰Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA
¹¹Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA
¹²BIOQUAL, Rockville, MD 20850, USA
¹³Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA
¹⁴Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA